Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Early Gliflozin for Elderly Patients With Acute Decompensated Heart Failure in the Emergency Department [NA]

View source ↗

Summary

Clinical trial update indicates a study of an SGLT2 inhibitor (gliflozin) for elderly patients with acute decompensated heart failure in the emergency departmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gliflozin (SGLT2 inhibitor)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Acute Heart Failure (AHF) | NA | Status: NOT_YET_RECRUITING